Market upgrade facilitates industry leading trading experience for U.S. investors
TORONTO, Dec. 4, 2017 /CNW/ – Liberty Health Sciences Inc. (CSE: LHS) (OTCQX: LHSIF) (“Liberty” or the “Company”), an industry leading investor and operator in the U.S. medical cannabis market, announced today that it has qualified to trade on the OTCQX® Best Market, an OTC Markets Group Inc. financial market. Liberty upgraded to OTCQX from the Pink® market.
Liberty begins trading today on OTCQX under the symbol “LHSIF”. U.S. investors can find current financial disclosure and Real-Time Level 2 quotes for the company on www.otcmarkets.com.
Qualifying to trade on OTCQX Best Market represents an important and exciting milestone for our company as we continue our targeted U.S. expansion. We’re committed to offering our growing U.S. investor base an industry leading trading experience and this step helps achieve that goal.
George Scorsis, CEO and Director of Liberty
Liberty was sponsored for OTCQX by Sichenzia Ross Ference Kesner LLP, a qualified third-party firm responsible for providing guidance on OTCQX requirements and recommending membership.
“OTCQX companies are distinguished by their commitment to providing a superior trading and information experience for their investors. We look forward to supporting Liberty Health Sciences in the public market,” said Jason Paltrowitz, Executive Vice President of Corporate Services at OTC Markets Group Inc.
For more information on Liberty please visit www.libertyhealthsciences.com
About Liberty Health Sciences Inc.
Liberty Health Sciences Inc. (“Liberty”) is an investor and operator in the medical cannabis market, capitalizing on new and existing opportunities in U.S. states where medical cannabis is legal. Liberty’s stringent investment criteria for expansion maximizes returns to shareholders, while focusing on significant near- and mid-term opportunities. Liberty leverages commercial greenhouse knowledge to deliver high-quality, clean and safe pharmaceutical grade cannabis to patients.
